Reify Health
Edit

Reify Health

http://www.reifyhealth.com/
Last activity: 24.09.2024
Active
Categories: CareDevelopmentFinTechFirmHealthTechInvestmentProductivityResearchSoftwareTechnology
StudyTeam, by Reify Health, is a cloud-based software that helps clinical trial teams achieve faster, more predictable enrollment while eliminating the tedious work that saps productivity and study budget. StudyTeam gives sponsors, CROs, and clinical research sites earlier visibility to the full enrollment picture, and the insight they need to focus people and capital on work that yields the greatest return.

The result is faster enrollment, stronger relationships between sponsors and clinical research sites, and higher return on R&D investment.
Likes
98
Website visits
7.9K /mo.
Mentions
44
Location: United States, Massachusetts, Boston
Employees: 201-500
Total raised: $470M
Valuation: $4.8B
Founded date: 2012

Investors 4

Funding Rounds 3

DateSeriesAmountInvestors
25.04.2022Series D$220M-
10.08.2021Series C$220M-
14.08.2020Series B$30M-

Mentions in press and media 44

DateTitleDescription
24.09.2024StudyTeam for Sites Reaches 10,000 Global Research Sites, Streamlining Clinical TrialsWhat You Should Know: – OneStudyTeam, a member of the Reify Health portfolio, provides the cloud-based software platform StudyTeam to accelerate the development of new and life-saving therapies. StudyTeam brings research site workflows onli...
29.06.2022Care Access Acquires IBPClin to Expand Decentralized Clinical Trial Capabilities to Latin AmericaWhat You Should Know: – Today, Care Access announced the acquisition of IBPClin, a leading clinical trial center in Rio de Janeiro. As a result, Care Access will bring its innovative approach to decentralized clinical research to Latin Amer...
25.04.2022Reify Health Raised $220M, Flipside Crypto Got $50M, and More Boston Tech NewsPhoto: Shutterstock Cryptocurrency, dental care and clinical trial infrastructure are among the buzzwords from Boston tech news last week. Keep reading to see what announcements you might have missed. This is the Built In Boston weekly refr...
25.04.2022Digital health news, funding roundup in the prior week; April 25, 2022Mount Sinai's new fund; DOJ appealed lifting of mask mandate; Amwell expanded to MSK and dermatology Top Health News Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System in New York, launched i3...
22.04.2022Reify Health announces $220M in new fundingReify Health has collected $220 million in Series D funding co-led by Altimeter Capital and Coatue, valuing the company at over $4.8 billion. Based in Boston, Reify Health offers clinical trial optimization tech and infrastructure to biopha...
22.04.2022Boston-Based Reify Health Raises $220M, Doubles Valuation to $4.8B Jobs at Reify HealthPhoto: Shutterstock Within a year, Reify Health, a tech-backed clinical health trial startup, pulled in $440 million in funding and has more than doubled its former $2.2 billion valuation announced in August. This week, the Boston-based sta...
21.04.2022Reify Health Lands $220M Series D Financing BOSTON, MA, Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, today announced a $220 million Series D round. >> Click here for more funding data on Reify Health >> To export Reify Healt...
21.04.2022Who is Chris Dixon?This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Considering that Chris Dixon, 50, is one of the most well-known venture capitalists in the indust...
21.04.2022Reify Health Raises $220M in Series D Funding; Valued at $4.8 BillionReify Health, a Boston, MA-based provider of solutions that empower the clinical trial ecosystem, raised $220M in Series D funding at a $4.8 Billion valuation. The round was co-led by Altimeter Capital and Coatue, joined by Dragoneer Invest...
21.04.2022Reify Health Secures $220M to Support Clinical Trial Diversity at $4.8B ValuationWhat You Should Know: – Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D funding round dedicated to improving diversity in clinical research. The investment comes less than ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In